A Phase IIa, Multi-center, Randomized, Double-bind, Double-dummy, Active and Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of AZD7268 in Patients With Major Depressive Disorder.
Phase of Trial: Phase II
Latest Information Update: 09 Apr 2012
At a glance
- Drugs AZD 7268; Escitalopram
- Indications Major depressive disorder
- Focus Therapeutic Use
- 09 Apr 2012 Actual patient number changed from 231 to 247 as reported by ClinicalTrials.gov.
- 08 May 2010 Actual patient number (231) added as reported by ClinicalTrials.gov.
- 08 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.